MDM2 SNP309 and SNP285 Act as Negative Prognostic Markers for Non-small Cell Lung Cancer Adenocarcinoma Patients

Objectives: Two functional polymorphisms in the MDM2 promoter region, SNP309T>G and SNP285G>C, have been shown to impact MDM2 expression and cancer risk. Currently available data on the prognostic value of MDM2 SNP309 in non-small cell lung cancer (NSCLC) is contradictory and unavailable for S...

Descripción completa

Detalles Bibliográficos
Autores principales: Deben, Christophe, Op de Beeck, Ken, Van den Bossche, Jolien, Jacobs, Julie, Lardon, Filip, Wouters, An, Peeters, Marc, Van Camp, Guy, Rolfo, Christian, Deschoolmeester, Vanessa, Pauwels, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5560132/
https://www.ncbi.nlm.nih.gov/pubmed/28819417
http://dx.doi.org/10.7150/jca.19254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5560132/
https://www.ncbi.nlm.nih.gov/pubmed/28819417
http://dx.doi.org/10.7150/jca.19254

Ejemplares similares